New Migraine Drugs, Erenumab and Fremanezumab, Show Promise
WEDNESDAY, Nov. 29, 2017 -- Two new migraine drugs have shown promise in late-stage clinical trials.
The drugs were designed specifically to target a pathway believed to be important in these headaches.
In stage 3 clinical trials, the drugs were...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news